Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study

OBJECTIVE: To assess the efficacy of recombinant human erythropoietin (rhEPO) in amyotrophic lateral sclerosis (ALS). METHODS: Patients with probable laboratory-supported, probable or definite ALS were enrolled by 25 Italian centres and randomly assigned (1:1) to receive intravenous rhEPO 40 000 IU...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Neurol Neurosurg Psychiatry
Главные авторы: Lauria, Giuseppe, Dalla Bella, Eleonora, Antonini, Giovanni, Borghero, Giuseppe, Capasso, Margherita, Caponnetto, Claudia, Chiò, Adriano, Corbo, Massimo, Eleopra, Roberto, Fazio, Raffaella, Filosto, Massimiliano, Giannini, Fabio, Granieri, Enrico, La Bella, Vincenzo, Logroscino, Giancarlo, Mandrioli, Jessica, Mazzini, Letizia, Monsurrò, Maria Rosaria, Mora, Gabriele, Pietrini, Vladimiro, Quatrale, Rocco, Rizzi, Romana, Salvi, Fabrizio, Siciliano, Gabriele, Sorarù, Gianni, Volanti, Paolo, Tramacere, Irene, Filippini, Graziella
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group 2015
Предметы:
Neuromuscular
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4515982/
https://ncbi.nlm.nih.gov/pubmed/25595151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2014-308996
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы